408 related articles for article (PubMed ID: 22252887)
1. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
Siddique HR; Saleem M
Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
[TBL] [Abstract][Full Text] [Related]
2. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
Wu KJ
Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
[TBL] [Abstract][Full Text] [Related]
3. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
4. Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.
Ding X; Lin Q; Ensenat-Waser R; Rose-John S; Zenke M
Stem Cells Dev; 2012 Jan; 21(1):121-32. PubMed ID: 21545235
[TBL] [Abstract][Full Text] [Related]
5. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
6. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells.
Schuringa JJ; Vellenga E
Curr Opin Hematol; 2010 Jul; 17(4):294-9. PubMed ID: 20308890
[TBL] [Abstract][Full Text] [Related]
7. BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells.
Chen H; Zhou L; Dou T; Wan G; Tang H; Tian J
Head Neck; 2011 Aug; 33(8):1115-25. PubMed ID: 21755556
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
Wu KJ; Yang MH
Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
[TBL] [Abstract][Full Text] [Related]
9. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
Crea F; Duhagon Serrat MA; Hurt EM; Thomas SB; Danesi R; Farrar WL
Int J Cancer; 2011 Apr; 128(8):1946-54. PubMed ID: 20568112
[TBL] [Abstract][Full Text] [Related]
10. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.
Liu L; Andrews LG; Tollefsbol TO
Oncogene; 2006 Jul; 25(31):4370-5. PubMed ID: 16501599
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 distinguishes immature retinal progenitor/stem cells from the main progenitor cell population and is required for normal retinal development.
Chatoo W; Abdouh M; Duparc RH; Bernier G
Stem Cells; 2010 Aug; 28(8):1412-23. PubMed ID: 20549707
[TBL] [Abstract][Full Text] [Related]
12. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
14. Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.
Alajez NM; Shi W; Hui AB; Yue S; Ng R; Lo KW; Bastianutto C; O'Sullivan B; Gullane P; Liu FF
Cell Death Differ; 2009 Nov; 16(11):1469-79. PubMed ID: 19575017
[TBL] [Abstract][Full Text] [Related]
15. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
16. Targeting BMI1
Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
[TBL] [Abstract][Full Text] [Related]
17. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
[TBL] [Abstract][Full Text] [Related]
18. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
19. Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells.
Yuan J; Takeuchi M; Negishi M; Oguro H; Ichikawa H; Iwama A
Leukemia; 2011 Aug; 25(8):1335-43. PubMed ID: 21527932
[TBL] [Abstract][Full Text] [Related]
20. Expression localization of Bmi1 in mice testis.
Zhang S; Li D; Li E; Li L; Wang J; Wang C; Lu J; Zhang X
Mol Cell Endocrinol; 2008 Jun; 287(1-2):47-56. PubMed ID: 18359150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
